• Return to Headlines

Biogen Inc has the Highest Sales per Share in the Biotechnology Industry (BIIB, REGN, UTHR, AMGN, GILD)

By Nick Russo

Below are the three companies in the Biotechnology industry with the highest sales per share. Sales per share is a valuable metric in comparing relative value for companies in the same industry.

Biogen Inc ranks highest with a sales per share of $57.76. Following is Regeneron Pharm with a sales per share of $55.21. United Therapeut ranks third highest with a sales per share of $39.25.

Amgen Inc follows with a sales per share of $31.27, and Gilead Sciences rounds out the top five with a sales per share of $19.97.

SmarTrend recommended that its subscribers protect gains by selling shares of Biogen Inc on February 6th, 2018 by issuing a Downtrend alert when the shares were trading at $327.03. Since that call, shares of Biogen Inc have fallen 18.4%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: highest sales per share biogen inc regeneron pharm united therapeut amgen inc Gilead Sciences

Ticker(s): BIIB REGN UTHR AMGN GILD